This appointment strengthens Korro's board with the addition...
This appointment strengthens Korro's board with the addition of Dr. Meyers' extensive experience in RNA-based medicines. This could potentially enhance Korro's ability to leverage their RNA editing platform and advance their lead product towards the clinic.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more